Mengbin Ding
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 27
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 10
- Co-authors
- Jingchao Li (24 shared papers)Ningyue Yu (18 shared papers)Deping Kong (3 shared papers)Haitao Sun (3 shared papers)Fengshuo Wang (3 shared papers)Liyun Zhu (2 shared papers)Xing Wang (2 shared papers)Xiangyang Shi (2 shared papers)
In The Last Decade
Mengbin Ding
30 papers receiving 660 citations
Peers
Comparison fields: 5 of 68
- Biomaterials 180
- Biomedical Engineering 524
- Immunology 126
- Molecular Medicine 22
- Materials Chemistry 172
Countries citing papers authored by Mengbin Ding
This map shows the geographic impact of Mengbin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengbin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengbin Ding more than expected).
Fields of papers citing papers by Mengbin Ding
This network shows the impact of papers produced by Mengbin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengbin Ding. The network helps show where Mengbin Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengbin Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 76 | |
| 2 | 2023 | 73 | |
| 3 | 2022 | 55 | |
| 4 | 2024 | 46 | |
| 5 | 2022 | 43 | |
| 6 | 2024 | 32 | |
| 7 | 2022 | 29 | |
| 8 | 2023 | 28 | |
| 9 | 2022 | 27 | |
| 10 | 2022 | 26 | |
| 11 | 2023 | 26 | |
| 12 | 2022 | 25 | |
| 13 | 2024 | 22 | |
| 14 | 2021 | 16 | |
| 15 | 2024 | 16 | |
| 16 | 2021 | 15 | |
| 17 | 2022 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2022 | 14 | |
| 20 | 2022 | 14 |
About Mengbin Ding
Mengbin Ding is a scholar working on Biomedical Engineering, Biomaterials, Immunology, Materials Chemistry and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 670 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (27 papers), Nanoparticle-Based Drug Delivery (10 papers), Photodynamic Therapy Research Studies (7 papers), Advanced Nanomaterials in Catalysis (7 papers), Extracellular vesicles in disease (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Immune cells in cancer (4 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Biomaterials (180 citations), Biomedical Engineering (524 citations), Immunology (126 citations), Molecular Medicine (22 citations) and Materials Chemistry (172 citations). Mengbin Ding has collaborated with scholars based in China, Singapore and Lebanon. Frequent co-authors include Jingchao Li, Ningyue Yu, Deping Kong, Haitao Sun, Fengshuo Wang, Liyun Zhu, Xing Wang, Xiangyang Shi, Yijing Zhang and Rong Cai. Their work appears in journals such as Advanced Materials, Journal of Materials Chemistry B, Nano Today, Frontiers in Chemistry and Nano Convergence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.